Chiral screening approach of atorvastatin diastereomers by HPLC method

Abstract :

The current study seeks to develop and validate a high-performance liquid chromatography method for atorvastatin diastereomer separation and analysis. In particular, we wish to identify the many diastereomers in atorvastatin, which can help us to better understand their pharmacological properties and provide significant information for pharmaceutical applications. Atorvastatin was chromatographed on a Chiralcel® OD-RH column and n-hexan-2-propanol (95:05 v/v) as the mobile phase, with an injection volume of 10 µL. The solution was pumped at a continuous flow rate of 1 mL/min, with a detection wavelength of 260 nm. The investigation found two peaks with retention times of 3.23 and 3.85 min, respectively. The resolution, capacity, and selectivity factors obtained were Rs = 1.2, k′1 = 3.50, k′2 = 4.37, and α = 1.24.

References
1. Murthy MV, Srinivas K, Kumar NR, Mukkanti K (2009) A validated LC method for determination of the enantiomeric purity of atorvastatin in bulk drug and dosage forms. Rasayan Journal of Chemistry. 2 (4): 836-841. doi: Nil.
2. Erturk S, Sevinc E¸ Ersoy L, Ficicioglu S (2003) An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets. Journal of Pharmaceutical and Biomedical Analysis. 33 (5): 1017-1023. doi: 10.1016/s0731-7085(03)00408-4
3. Raul SK, Aravelli AB, Jhansi D (2015) Rp-Hplc method development and validation for the simultaneous estimation of atorvastatin and ezetimibe in pharmaceutical dosage form. Asian Journal of Pharmaceutical and Clinical Research. 8 (2) 178-181. Corpus ID: 93275338.
4. Patel A, Macwana C, Parmar V, Patel S (2012) Simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in a tablet formulation by HPLC. Journal of AOAC International. 95 (2): 419-423. doi: 10.5740/jaoacint.1-095
5. Kublin E, Malanowicz E, Kaczmarska-Graczyk B, Czerwinska K, Wyszomirska E, Mazuurek AP (2015) Development of chromatographic method for determination of drugs reducing cholesterol level -- statins and ezetimibe. Acta Poloniae Pharmaceutica. 72 (3): 429-437. PMID: 26642651.
6. Alam S, Saleem S, Naveed S, Dilshad H, Qamar F, Alam T, Sadia H, Khan S, Karim M, Amanullah Khan (2018) HPLC method development and validation of atorvastatin calcium in bulk and tablet dosage form. RADS Journal of Pharmacy and Pharmaceutical Sciences. 6 (1): 83-87. Corpus ID: 139628780.
7. Sultana N, Arayneb SA, Naveed S (2010) Simultaneous determination of captopril and statins in API, pharmaceutical formulations and in human serum by RP-HPLC. Journal of the Chinese Chemical Society. 57 (3A): 378-383. doi: 10.1002/jccs.201000056
8. Sangshetti JN, Aqeel M, Zaheer Z, Ahmed RZ, Dehghan MHG, Indrajeet G (2016) Development and validation of RP-HPLC method for determination of atorvastatin calcium and nicotinic acid in combined tablet dosage form. Journal of Saudi Chemical Society. 20 (S1): S328-S333. doi: 10.1016/j.jscs.2012.12.005
9. Ganesh M, Hemalatha P, Sakthi K, Peng M, Seung G (2012) Simultaneous estimation of atorvastatin and ezetimibe in combined formulation by RP-HPLC. Asian Journal of Chemistry. 24 (4): 1867-1871. doi: Nil.
10. Kumar M, Kayankar A, Ragampeta S (2012) Synchronized separation of Atorvastatin an antihyperlipidemic drug with an antihypertensive, antidiabetic, antithrombotic drugs by RP-LC for determination combined formulations. Journal of Pharmaceutical Analysis. 2 (4): 285-292. doi: 10.1016/j.jpha.2012.02.006
11. Alnowaiser MA (2013) Simultaneous determination of amlodipine and atorvastatin in Caduet® tablets using HPLC. American Journal of Applied Sciences. 10 (8): 849-852. doi: 10.3844/ajassp.2013.849.852
12. Kurakula M, Sobahi T, El-Helw A, Abdelaal MY (2014) Development and validation of a RP-HPLC method for assay of atorvastatin and its application in dissolution studies on thermosensitive hydrogel-based nanocrystals. Tropical Journal of Pharmaceutical Research. 13 (10): 1681-1687. doi. 10.4314/tjpr.v13i10.16
13. Bahrami G, Mohammadi B, Mirzaeei S, Kiani A (2005) Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 826 (1-2): 41-45. doi: 10.1016/j.jchromb.2005. 08.008.
14. Qutab SS, Razzaq SN, Khan IU, Ashfaq M, Shuja ZA (2007) Simultaneous determination of atorvastatin calcium and ezetimibe in pharmaceutical formulations by liquid chromatography. Journal of Food and Drug Analysis. 15 (2): 139-144. doi: 10.38212/2224-6614.2433
15. Addadi K, Sekkoum K, belboukhari N, Cheriti A, Aboul-Enein H (2015) Screening approach for chiral separation of β-aminoketones by HPLC on various polysaccharide-based chiral stationary phases. Chirality. 27 (5): 332-338. doi: 10.1002/chir.22434
16. Zarghi A, Shafaati A, Foroutan SM, Khoddam A (2005) A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies. Arzneimittel-forschung. 55 (8): 451-454. doi: 10.1055/s-0031-1296887
17. Rupali H, Ravindra B, Manish K (2010) RP-HPLC method for simultaneous estimation of Atorvastatin Calcium and Fenofibrate in tablet dosage forms. Journal of Pharmacy Research. 3 (10): 2400-2401. doi: Nil.
18. Akabari A, Mistry P, kumar Patel S, Surati J, Patel S, Shah U (2023) Simultaneous estimation of fimasartan potassium trihydrate and atorvastatin calcium with greenness assessment using HPLC and UV Spectrophotometric methods. Green Analytical Chemistry. 6: 100067. doi: 10.1016/j.greeac.2023.100067
19. Seshachalam U, Kothapally CB (2008) HPLC analysis for simultaneous determination of atorvastatin and ezetimibe in pharmaceutical formulations. Journal of Liquid Chromatography and Related Technologies. 31 (5): 714-721. doi: 10.1080/10826070701854402
20. Pasha MK, Muzeeb S, Basha SJS, Shashikumar D, Mullangi R, Srinivas NR (2006) Analysis of five HMG-COA reductase inhibitors atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. Biomedical Chromatography. 20 (3): 282-293. doi: 10.1002/bmc.561.
21. Bounoua N, Sekkoum K, Belboukhari N, Cheriti A, Aboul-Enein H (2016) Achiral and chiral separation and analysis of antifungal drugs by HPLC and CE: a comparative study-mini review. Journal of Liquid Chromatography and Related Technologies. 39 (11): 513-519. doi: 10.1080/10826076.2013.1174942
22. (2020) The Theory of HPLC Chromatographic Parameters, Crawford Scientific. 1-22. CHROMacademy. The USA.
23. Kormany R, Molnar I, Rieger H-J (2013) Explorions better column selectivity choices in ultra-high performance liquid chromatography using quality by design principles. Journal of Pharmaceutical and Biomedical Analysis. 80C: 79- 88. doi: 10.1016/j.jpba.2013.02.028
24. Addadi K, Sekkoum K, Belboukhari N, ALOthman ZA, Aljuwayid AM, Sillanpaa, Ali I (2023) Enantio-resolution of some chiral sulfoxide drugs on amylose and cellulose-based stationary phases: Elution order, absolute configuration and chiral mechanism determination. Microchemical Journal. 193. 109019. doi: 10.1016/ j.microc.2023.109019
25. Oum Keltoum CBB, El Amin ZM, Nasser B, Sekkoum Khaled S, Hassan A-E (2023) Synthesis and chiral separation of some new derivatives of imidazo[1,2-a] pyridine. Current Analytical Chemistry. 19 (6): 482-488. doi: 10.2174/1573411019666230626162832

Citation :

Hamache et al. (2024) Chiral screening approach of atorvastatin diastereomers by HPLC method. Mediterr J Pharm Pharm Sci. 4 (1): 121-125. [Article number: 150]. https://doi.org/10.5281/zenodo.10814722